These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 34311708)
1. Associations between elevated kidney and liver biomarker ratios, metabolic syndrome and all-cause and coronary heart disease (CHD) mortality: analysis of the U.S. National Health and Nutrition Examination Survey (NHANES). Oye-Somefun A; Kuk JL; Ardern CI BMC Cardiovasc Disord; 2021 Jul; 21(1):352. PubMed ID: 34311708 [TBL] [Abstract][Full Text] [Related]
2. Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001-2018. Duan M; Zhao X; Li S; Miao G; Bai L; Zhang Q; Yang W; Zhao X Cardiovasc Diabetol; 2024 Jul; 23(1):243. PubMed ID: 38987779 [TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes. Gurka MJ; Guo Y; Filipp SL; DeBoer MD Cardiovasc Diabetol; 2018 Jan; 17(1):17. PubMed ID: 29351794 [TBL] [Abstract][Full Text] [Related]
4. Associations of a metabolic syndrome severity score with coronary heart disease and diabetes in fasting vs. non-fasting individuals. DeBoer MD; Filipp SL; Gurka MJ Nutr Metab Cardiovasc Dis; 2020 Jan; 30(1):92-98. PubMed ID: 31662283 [TBL] [Abstract][Full Text] [Related]
5. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study. Pokharel Y; Sun W; Villareal DT; Selvin E; Virani SS; Ndumele CE; Hoogeveen RC; Coresh J; Boerwinkle E; Butler KR; Solomon SD; Pankow JS; Bozkurt B; Ballantyne CM; Nambi V Eur J Prev Cardiol; 2017 Apr; 24(6):628-638. PubMed ID: 27941157 [TBL] [Abstract][Full Text] [Related]
6. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Ruhl CE; Everhart JE Gastroenterology; 2009 Feb; 136(2):477-85.e11. PubMed ID: 19100265 [TBL] [Abstract][Full Text] [Related]
7. Cystatin C Is a Predictor for Long-Term, All-Cause, and Cardiovascular Mortality in US Adults With Metabolic Syndrome. Song X; Xiong L; Guo T; Chen X; Zhang P; Zhang X; Liang Z J Clin Endocrinol Metab; 2024 Oct; 109(11):2905-2919. PubMed ID: 38597157 [TBL] [Abstract][Full Text] [Related]
8. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067 [TBL] [Abstract][Full Text] [Related]
9. Maximal exercise electrocardiographic responses and coronary heart disease mortality among men with metabolic syndrome. Lyerly GW; Sui X; Church TS; Lavie CJ; Hand GA; Blair SN Mayo Clin Proc; 2010 Mar; 85(3):239-46. PubMed ID: 20160139 [TBL] [Abstract][Full Text] [Related]
10. Association Between Metabolic Syndrome and Mortality: Prospective Cohort Study. Li W; Chen D; Peng Y; Lu Z; Kwan MP; Tse LA JMIR Public Health Surveill; 2023 Sep; 9():e44073. PubMed ID: 37669100 [TBL] [Abstract][Full Text] [Related]
11. Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China. Zhou J; Gao Q; Wang J; Zhang M; Ma J; Wang C; Chen H; Peng X; Hao L BMJ Open; 2018 Oct; 8(10):e022974. PubMed ID: 30366915 [TBL] [Abstract][Full Text] [Related]
12. Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants. Rahmani J; Miri A; Namjoo I; Zamaninour N; Maljaei MB; Zhou K; Cerneviciute R; Mousavi SM; Varkaneh HK; Salehisahlabadi A; Zhang Y Eur J Gastroenterol Hepatol; 2019 May; 31(5):555-562. PubMed ID: 30614883 [TBL] [Abstract][Full Text] [Related]
13. Interrelationships among abnormal P-wave axis, metabolic syndrome and its components, and mortality in US adults. Wang Y; Zhang T; Zhang Y; Huang Z; Guo Q; Lan C; Deng L; Liu Y; Wu M; Yu P; Lin L; Liao Y J Electrocardiol; 2024; 84():137-144. PubMed ID: 38696980 [TBL] [Abstract][Full Text] [Related]
14. Serum Nutritional Biomarkers and All-Cause and Cause-Specific Mortality in U.S. Adults with Metabolic Syndrome: The Results from National Health and Nutrition Examination Survey 2001-2006. Peng X; Zhu J; Lynn HS; Zhang X Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771258 [TBL] [Abstract][Full Text] [Related]
15. An examination of sex and racial/ethnic differences in the metabolic syndrome among adults: a confirmatory factor analysis and a resulting continuous severity score. Gurka MJ; Lilly CL; Oliver MN; DeBoer MD Metabolism; 2014 Feb; 63(2):218-25. PubMed ID: 24290837 [TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome in Russian adults: associated factors and mortality from cardiovascular diseases and all causes. Sidorenkov O; Nilssen O; Grjibovski AM BMC Public Health; 2010 Sep; 10():582. PubMed ID: 20920226 [TBL] [Abstract][Full Text] [Related]
17. Low serum high density lipoprotein is associated with the greatest risk of metabolic syndrome among U.S. adults. Castaneda G; Bhuket T; Liu B; Wong RJ Diabetes Metab Syndr; 2018; 12(1):5-8. PubMed ID: 28826579 [TBL] [Abstract][Full Text] [Related]
18. Linear positive association of metabolic score for insulin resistance with stroke risk among American adults: a cross-sectional analysis of National Health and Nutrition Examination Survey datasets. Zheng R; Dong X; Wang T; Zhang H; Zhou Y; Wang D J Stroke Cerebrovasc Dis; 2024 Nov; 33(11):107994. PubMed ID: 39241846 [TBL] [Abstract][Full Text] [Related]
19. Coronary Artery Calcium Score for Long-term Risk Classification in Individuals With Type 2 Diabetes and Metabolic Syndrome From the Multi-Ethnic Study of Atherosclerosis. Malik S; Zhao Y; Budoff M; Nasir K; Blumenthal RS; Bertoni AG; Wong ND JAMA Cardiol; 2017 Dec; 2(12):1332-1340. PubMed ID: 29117273 [TBL] [Abstract][Full Text] [Related]
20. Association of inflammatory score with all-cause and cardiovascular mortality in patients with metabolic syndrome: NHANES longitudinal cohort study. Chen Y; Ju H; Xie K; Zhao X Front Immunol; 2024; 15():1410871. PubMed ID: 39011047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]